Molecular Templates, Inc.
Open: 2:55 PM
MTEM Stock Price Graph
MTEM Stock Price Today
Molecular Templates, Inc. (MTEM) stock rallied over 3.31% intraday to trade at $4.99 a share on NASDAQ. The stock opened with a gain of 21.40% at $5.92 and touched an intraday high of $6.00, rising 2.25% against the last close of $4.88. The Molecular Templates, Inc. in stock market went to a low of $5.70 during the session.
MTEM Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
MTEM Stock Price History Chart
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Frequently Asked Questions
What is the current Molecular Templates, Inc. (MTEM) stock price?
Molecular Templates, Inc. (NASDAQ: MTEM) stock price is $4.99 in the last trading session. During the trading session, MTEM stock reached the peak price of $6.00 while $5.70 was the lowest point it dropped to. The percentage change in MTEM stock occurred in the recent session was 3.31% while the dollar amount for the price change in MTEM stock was $0.16.
MTEM's industry and sector of operation?
The NASDAQ listed MTEM is part of Biotechnology industry that operates in the broader Healthcare sector. Molecular Templates, Inc. , a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases.
Who are the executives of MTEM?
Dr. Erin Willert Ph.D.
Executive Vice President of R&D
Dr. Jen-Sing Liu Ph.D.
Executive Vice President of Manufacturing
Dr. Eric E. Poma Ph.D.
Chief Executive Officer, Chief Scientific Officer & Director
Mr. Michael Dowd
Senior Vice President of Project & Alliance Management
How MTEM did perform over past 52-week?
MTEM's closing price is 0.35% higher than its 52-week low of $4.65 where as its distance from 52-week high of $10.2 is -0.76%.
How many employees does MTEM have?
Number of MTEM employees currently stands at N/A. MTEM operates from 9301 Amberglen Boulevard, Austin, TX 78729, US.
Link for MTEM official website?
Official Website of MTEM is: https://www.mtem.com
How do I contact MTEM?
How many shares of MTEM are traded daily?
MTEM stock volume for the day was 9537.00 shares. The average number of MTEM shares traded daily for last 3 months was 8.11 Thousands.
What is the market cap of MTEM currently?
The market value of MTEM currently stands at $26.8 Million with its latest stock price at $4.99 and N/A of its shares outstanding.